Lilly to acquire Disarm Therapeutics
THe FINANCIAL -- Eli Lilly and Company (NYSE: LLY) announced a definitive agreement to acquire Disarm Therapeutics, a privately-held biotechnology company ...
ADVERTISEMENT
Tag: lilly to acquire Disarm Therapeutics
ADVERTISEMENT
Popular Last 24h
-
Childhood tuberculosis cases rise by 10%: a disturbing wake-up call for Europe
-
Ampersand wins £22m five-year contract at London Zoo
-
The London Diplomatic List, Addresses, Contacts & Working Hours
-
Optimist Fund Exits Following Xponential Fitness’ Founder-CEO Resignation
-
Future-Proofing Your Workplace: Adapting to the Needs of a Modern Workforce
-
Who Is the Owner of QI Company? A Look at the QI Group’s Leadership Shaping Its Future
-
Gold price hit its highest since 2012
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
